Immunicum announces INTUVAX phase I/II data at ASCO 2014

Immunicum announces INTUVAX phase I/II data at ASCO 2014

ASCO 2014

DTA Works with LARTA and TATRC SBIR Companies

DTA Works with LARTA and TATRC SBIR Companies

LARTA is the leading commercialization partner for government sponsored R&D companies.

DTA Collaborates with Innovative Mexican Organizations

DTA Collaborates with Innovative Mexican Organizations

DTA Collaborates with Mexican Innovation Groups

QUICK TABS

Diagnostic and Defense Technology Analysts (DTA) provides world class commercialization and business development. Our focus areas include advanced technologies with applications in diagnostics manufacturing, Homeland Security and Department of Defense.

Immunicum announces INTUVAX phase I/II data at ASCO 2014

Immunicum AB, a bio-pharmaceutical company developing therapeutic
cancer vaccines, today announced that phase I/II data has been presented
during a general poster session at the American Society of Clinical Oncology
(ASCO) 2014 annual meeting on the Company’s clinical candidate, INTUVAX, in
patients with metastasized renal cell carcinoma (mRCC).